Alobresib
Alobresib Uses, Dosage, Side Effects, Food Interaction and all others data.
Alobresib is under investigation in clinical trial NCT02607228 (Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer).
Trade Name | Alobresib |
Generic | Alobresib |
Alobresib Other Names | Alobresib |
Type | |
Formula | C26H23N5O2 |
Weight | Average: 437.503 Monoisotopic: 437.185175001 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Alobresib